FDA Inspection 1223522 — Vitalant
The FDA completed an inspection of Vitalant on Nov 9, 2023 in Tempe, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 9, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tempe, AZ (United States)